Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Calatzis, A."'
Autor:
Ponschab, Martin, van Griensven, Martijn, Heitmeier, Stefan, Laux, Volker, Schlimp, Christoph J., Calatzis, Andreas, Bahrami, Soheyl, Redl, Heinz, Schöchl, Herbert
Publikováno v:
In Thrombosis Research November 2016 147:115-121
Autor:
Nickel, Thomas *, Lackermair, K. *, Scherr, J. *, Calatzis, A., Vogeser, M., Hanssen, H., Waidhauser, G., Schönermark, U., Methe, H., Horster, S., Wilbert-Lampen, U., Halle, M.
Publikováno v:
In The Journal of nutrition, health and aging June 2016 20(6):586-593
Autor:
Badr Eslam, Roza, Lang, Irene M., Koppensteiner, Renate, Calatzis, Andreas, Panzer, Simon, Gremmel, Thomas
Publikováno v:
In International Journal of Cardiology 20 September 2013 168(1):403-406
Autor:
Cristina Solomon, Michael Winterhalter, Isabel Gilde, Ludwig Hoy, Andreas Calatzis, Niels Rahe-Meyer
Publikováno v:
Medical Devices: Evidence and Research, Vol 2008, Iss default, Pp 23-30 (2008)
Cristina Solomon1, Michael Winterhalter1, Isabel Gilde1, Ludwig Hoy2, Andreas Calatzis3, Niels Rahe-Meyer11Department of Anesthesiology, Hannover Medical School, Hannover, Germany; 2Institute for Biometry, Hannover Medical School, Hannover, Germany;
Externí odkaz:
https://doaj.org/article/0e3360b306954bb4a1df98aa182273fd
Autor:
Andreas Giebl, Stefanie Grützner, Michael Spannagl, Christian Pfrepper, Annelie Siegemund, Geli Calatzis, Isabell Pekrul
Publikováno v:
Haemophilia. 27
INTRODUCTION A dedicated emicizumab assay based on the modified one-stage factor VIII (FVIII) assay (mOSA) is mainly available in haemophilia treatment centres (HTC). A method to estimate emicizumab plasma levels based on a widely available assay wou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b61bb194948145ed284d97d3b8c867
https://doi.org/10.1111/hae.14264
https://doi.org/10.1111/hae.14264
Publikováno v:
In Thrombosis Research 2007 121(2):249-258
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lorenz Reinhard, Tóth Orsolya, Bernlochner Isabell, Penz Sandra M, Calatzis Andreas, Siess Wolfgang
Publikováno v:
Thrombosis Journal, Vol 8, Iss 1, p 9 (2010)
Abstract Background Poor platelet inhibition by aspirin or clopidogrel has been associated with adverse outcomes in patients with cardiovascular diseases. A reliable and facile assay to measure platelet inhibition after treatment with aspirin and a P
Externí odkaz:
https://doaj.org/article/1400a16555ba4ef0aefcb536cc736cfb
Autor:
Gremmel, Thomas1 (AUTHOR), Calatzis, Andreas2 (AUTHOR), Steiner, Sabine1 (AUTHOR), Kaider, Alexandra3 (AUTHOR), Seidinger, Daniela1 (AUTHOR), Koppensteiner, Renate1 (AUTHOR), Kopp, Christoph W.1 (AUTHOR), Panzer, Simon4 (AUTHOR) simon.panzer@meduniwien.ac.at
Publikováno v:
Platelets. Nov2010, Vol. 21 Issue 7, p515-521. 7p. 3 Charts, 2 Graphs.
Autor:
Renate Koppensteiner, Simon Panzer, Thomas Gremmel, I.M. Lang, Roza Badr Eslam, Andreas Calatzis
Publikováno v:
International Journal of Cardiology. 168:403-406
Dual antiplatelet therapy with aspirin and thienopyridines has improved outcomes of patients after coronary stent implantation. However, current knowledge suggests that thrombin generation is not affected by inhibition of the P2Y12 receptor, and ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fdea9753d3117e86ae6d7dd6c567f06
https://doi.org/10.1016/j.ijcard.2012.09.103
https://doi.org/10.1016/j.ijcard.2012.09.103